NCT00785343

Trial name or title	Effectiveness of adding robotic therapy to conventional therapy for acute stroke patients with upper extremity paresis
Methods	RCT
Participants	Country: USA Participants: estimated enrolment n = 40 Inclusion criteria: age between 65 and 84 years; right‐hemispheric unilateral ischaemic stroke; time since stroke < 15 days; arm weakness; right‐handedness; MRC grade ≥ 2; being able to follow 2‐3 step commands; head, neck, and trunk control; maintain upright posture for at least 45 minutes; some synergistic movements at shoulder flexion or abduction > 30°; ≥ 45° elbow flexion Exclusion criteria: previous stroke; haemorrhagic, cerebellar stroke or subarachnoid haemorrhage; contractures in the involved upper extremity; moderate to severe muscle tone in the involved upper extremity; full, active isolated movement of the involved upper extremity; corrected visual acuity worse than 20/50 for distance; cognitive or other deficits that would negatively affect their ability to follow directions or track visual targets; unstable cardiovascular, orthopaedic, or neurological conditions that would preclude exercise in short‐duration, high‐workload trials
Interventions	Experimental group: ReoGo robotic arm trainer additional to conventional therapy Control group: conventional therapy
Outcomes	Outcomes will be collected at baseline and at study end Primary outcomes: FMA Secondary outcomes: EMG ‐ muscle activation and co‐contraction index
Starting date	September 2008
Contact information	Lauren McDonagh, PT; lmcdonagh@KESSLER‐REHAB.com Christine Post, OT; CHPost@selectmedicalcorp.com
Notes